A case of lower gingival carcinoma with drug-induced interstitial pneumonia caused after chemotherapy with peplomycin ☆

作者: Nobuharu Yamamoto , Yuma Fuse , Yoshifumi Yoshida , Taiki Suzuki , Sunaki Noguchi

DOI: 10.1016/J.AJOMS.2013.09.003

关键词:

摘要: Abstract Interstitial pneumonia is one of the most frequently encountered clinical conditions as an adverse effect caused by peplomycin (PEP). We report our experience interstitial case induced PEP administration at relatively low dosage (27.5 mg) for lower gingival carcinoma. A 78-year-old male. The patient was diagnosed carcinoma right gingiva (T2N0M0). For course treatment, a total 27.5 mg administered intramuscularly in 6 doses preoperative chemotherapy from February 2013. developed fever over 38 degrees 2 days before surgery. As result chest X-ray, mild diffuse change observed both lung fields; therefore, antimicrobial drug after consultation with Department Respiratory Medicine. In X-ray conducted reevaluation 16 initiation administration, ground-glass pattern fields became worse, and drug-induced pneumonia. Steroid therapy started same day. less severe CT obtained 26 steroid therapy. Radiotherapy instead, tumor completely disappeared irradiation 80 Gy, currently under follow-up. Mechanisms underlying toxicity remains incompletely understood; it considered that adequate attention would be required to development even if dose were not high.

参考文章(9)
Franco M. Muggia, Arthur C. Louie, Branimir I. Sikic, Pulmonary toxicity of antitumor agents Cancer Treatment Reviews. ,vol. 10, pp. 221- 243 ,(1983) , 10.1016/0305-7372(83)90012-9
Hisashi Oku, Toshikatsu Shimizu, Tomoji Kawabata, Morio Nagira, Ichiro Hikita, Azumi Ueyama, Shuuichi Matsushima, Mikinori Torii, Akinori Arimura, Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. European Journal of Pharmacology. ,vol. 590, pp. 400- 408 ,(2008) , 10.1016/J.EJPHAR.2008.06.046
Gary J. Dee, John H. M. Austin, George L. Mutter, Bleomycin-associated pulmonary fibrosis: rapidly fatal progression without chest radiotherapy. Journal of Surgical Oncology. ,vol. 35, pp. 135- 138 ,(1987) , 10.1002/JSO.2930350215
Ono S, Shimizu T, Nishikawa K, Akasu I, Watanabe K, [A case of recurrent lung cancer complicated acute interstitial pneumonia, just after injected peplomycin]. Gan to kagaku ryoho. Cancer & chemotherapy. ,vol. 17, pp. 1941- ,(1990)
Takahashi K, Okada M, Ito J, Ekimoto H, [Effects of anti-platelet aggregating agents on peplomycin induced pulmonary toxicity in mice]. Japanese Journal of Transfusion and Cell Therapy. ,vol. 24, pp. 793- ,(1989)
Watanabe S, Shimosato Y, Baba K, [Pulmonary lesions produced by antitumor drugs--studies on autopsy cases]. Gan no rinsho. Japan journal of cancer clinics. ,vol. 17, pp. 21- 34 ,(1971)
Akinori IWASAKI, Yumiko OHBAYASHI, Takaaki OGAWA, Minoru MIYAKE, Shunichiro NAGAHATA, Yoshiro MATSUI, Nedaplatin・5-FU併用療法により間質性肺炎を発症した舌, 肺重複癌の1例 Japanese Journal of Oral and Maxillofacial Surgery. ,vol. 56, pp. 645- 649 ,(2010) , 10.5794/JJOMS.56.645
Masahiro Umeda, Yasutaka Ojima, Hideki Komatsubara, Takashi Shigeta, Tsutomu Minamikawa, Yasuyuki Shibuya, Satoshi Yokoo, Masataka Fukuda, Naruki Nishimatsu, Takahide Komori, Journal of Japan Society for Oral Tumors. ,vol. 19, pp. 177- 181 ,(2007) , 10.5843/JSOT.19.177